BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1618777)

  • 1. Adipsin and an endogenous pathway of complement from adipose cells.
    Choy LN; Rosen BS; Spiegelman BM
    J Biol Chem; 1992 Jun; 267(18):12736-41. PubMed ID: 1618777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of alternative pathway activation and C3a production by adipose cells.
    Choy LN; Spiegelman BM
    Obes Res; 1996 Nov; 4(6):521-32. PubMed ID: 8946437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipsin and complement factor D activity: an immune-related defect in obesity.
    Rosen BS; Cook KS; Yaglom J; Groves DL; Volanakis JE; Damm D; White T; Spiegelman BM
    Science; 1989 Jun; 244(4911):1483-7. PubMed ID: 2734615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue.
    White RT; Damm D; Hancock N; Rosen BS; Lowell BB; Usher P; Flier JS; Spiegelman BM
    J Biol Chem; 1992 May; 267(13):9210-3. PubMed ID: 1374388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve.
    Cook KS; Min HY; Johnson D; Chaplinsky RJ; Flier JS; Hunt CR; Spiegelman BM
    Science; 1987 Jul; 237(4813):402-5. PubMed ID: 3299705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes.
    Peake PW; O'Grady S; Pussell BA; Charlesworth JA
    Eur J Clin Invest; 1997 Nov; 27(11):922-7. PubMed ID: 9395788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acylation-stimulating protein precursor proteins in adipose tissue in human obesity.
    Xia Z; Cianflone K
    Metabolism; 2003 Oct; 52(10):1360-6. PubMed ID: 14564690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of complement components in omental adipose tissue in obese men.
    Gabrielsson BG; Johansson JM; Lönn M; Jernås M; Olbers T; Peltonen M; Larsson I; Lönn L; Sjöström L; Carlsson B; Carlsson LM
    Obes Res; 2003 Jun; 11(6):699-708. PubMed ID: 12805391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice.
    Paglialunga S; Fisette A; Yan Y; Deshaies Y; Brouillette JF; Pekna M; Cianflone K
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E521-9. PubMed ID: 18160458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and complement d activity of porcine adipsin.
    Miner JL; Hahn KJ; Spurlock ME; Staten NR
    Protein Expr Purif; 2001 Oct; 23(1):14-21. PubMed ID: 11570841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of body weight and caloric restriction on serum complement proteins, including Factor D/adipsin: studies in anorexia nervosa and obesity.
    Pomeroy C; Mitchell J; Eckert E; Raymond N; Crosby R; Dalmasso AP
    Clin Exp Immunol; 1997 Jun; 108(3):507-15. PubMed ID: 9182900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severely impaired adipsin expression in genetic and acquired obesity.
    Flier JS; Cook KS; Usher P; Spiegelman BM
    Science; 1987 Jul; 237(4813):405-8. PubMed ID: 3299706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acylation stimulating protein-adipsin system.
    Cianflone K; Maslowska M; Sniderman A
    Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S34-8. PubMed ID: 7550536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic-cyclic AMP signalling pathway modulates cell function at the transcriptional level in 3T3-F442A adipocytes.
    Antras J; Lasnier F; Pairault J
    Mol Cell Endocrinol; 1991 Dec; 82(2-3):183-90. PubMed ID: 1665451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced adipsin expression in murine obesity: effect of age and treatment with the sympathomimetic-thermogenic drug mixture ephedrine and caffeine.
    Lowell BB; Napolitano A; Usher P; Dulloo AG; Rosen BS; Spiegelman BM; Flier JS
    Endocrinology; 1990 Mar; 126(3):1514-20. PubMed ID: 2307116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of adipsin expression is secondary to the onset of obesity in db/db mice.
    Dugail I; Quignard-Boulangé A; Le Liepvre X; Lavau M
    J Biol Chem; 1990 Feb; 265(4):1831-3. PubMed ID: 2404973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of complement alternative pathway in mice with Fab antibody to recombinant adipsin/factor D.
    Pascual M; Catana E; White T; Spiegelman BM; Schifferli JA
    Eur J Immunol; 1993 Jun; 23(6):1389-92. PubMed ID: 8500532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass.
    Napolitano A; Lowell BB; Damm D; Leibel RL; Ravussin E; Jimerson DC; Lesem MD; Van Dyke DC; Daly PA; Chatis P
    Int J Obes Relat Metab Disord; 1994 Apr; 18(4):213-8. PubMed ID: 8044195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in sympathetic nervous system activity do not regulate adipsin gene expression in mice.
    Napolitano A; Lowell BB; Flier JS
    Int J Obes; 1991 Mar; 15(3):227-35. PubMed ID: 1646181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipsin gene expression in 3T3-F442A adipocytes is posttranscriptionally down-regulated by retinoic acid.
    Antras J; Lasnier F; Pairault J
    J Biol Chem; 1991 Jan; 266(2):1157-61. PubMed ID: 1985940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.